ALPN-202 With PD-1 Inhibition in Advanced Malignancies

Clinical trial NCT04920383 · TERMINATED

Trial details

NCT number: NCT04920383
Sponsor: Alpine Immune Sciences, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Lymphoma

Start date: 2021-06-22
Primary completion: 2022-11-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.